FDA Inspection
Rising Pharma Holdings, IncRising Pharma Holdings, Inc – FDA Inspection, Apr 8, 2022
Record Details
This FDA Inspection record concerns Rising Pharma Holdings, Inc, with an inspection on April 8, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Rising Pharma Holdings, Inc
- Inspection Date
- April 8, 2022
- Product Type
- Drugs
View Company Profile
ID · 5900995e-df55-4f67-93a4-117713ee8ee7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1166630
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Rising Pharma Holdings, Inc
16| Date | Classification | Office | Project area |
|---|---|---|---|
| May 16, 2018 | OAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| April 26, 2017 | VAI | Chicago District Office | Pre-Approval Eval. of Animal Drugs and Food Additives |
| December 9, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 10, 2016 | OAI | Center for Devices and Radiological Health | Compliance: Devices |
| June 6, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Rising Pharma Holdings, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.